• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Montefiore Health to Create AI-Based Screening Tool to Help Doctors Identify Lung Failure

by Jasmine Pennic 10/23/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

 Montefiore Health to Create AI-Based Screening Tool to Help Doctors Identify Lung Failure

 Funded by a $1.2 million Agency for Healthcare Research and Quality grant, Montefiore Health System is building a new artificial intelligence (AI) screening tool to help doctors better identify and treat acute respiratory distress syndrome (ARDS), a deadly, but under-recognized, form of lung failure. Acute respiratory distress syndrome (ARDS) is a rapidly progressive disease occurring in critically ill patients.

The main complication in ARDS is that fluid leaks into the lungs making breathing difficult or impossible. Approximately 200,000 people in the United States suffer from  ARDS and is often fatal as risk increases with age and severity of illness. The biggest challenge for doctors is that up to 40 percent of the time it can be missed. 

To resolve this, researchers and data and computer scientists are building off of Montefiore Einstein’s existing AI platform, combing through years of de-identified patient data to determine dozens of critical, objective data points for ARDS. After developing a profile, the AI  screening tool will run in the background of the electronic medical record system, flagging any patients who match the profile created for ARDS. This ARDS-specific tool is an extension of the work already conducted by the Critical Care and health data teams at Montefiore Einstein, which shows that AI can improve outcomes for people with another lung condition—severe acute respiratory failure.

“ARDS is under-recognized because these patients are often extremely ill and have other life-threatening conditions, such as shock, pneumonia, or trauma. Since diagnosis depends on the patient meeting a number of criteria, it is easy for one of the criteria to be attributed to another acute condition, rather than to ARDS,” said Dr. Michelle Ng Gong, chief of Research, Critical Care at Montefiore Health System and professor of medicine and of epidemiology & population health at Albert Einstein College of Medicine. “By using new technology we hope to help clinicians identify ARDS as early as possible, when treatment may be most effective.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Lung Cancer, Montefiore Health, respiratory disease

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |